Disease | retinitis |
Phenotype | C0024440|cystoid macular oedema |
Sentences | 2 |
PubMedID- 23782868 | Aim: to evaluate the therapeutic effect of continuous treatment with topical dorzolamide (a carbonic anhydrase inhibitor) for cystoid macular oedema (cme) associated with retinitis pigmentosa (rp). |
PubMedID- 24688265 | Inhibition of carbonic anhydrase with acetazolamide has previously been shown to result in increased retinal pump activity [7], and has been used in this regard to treat cystoid macular oedema associated with retinitis pigmentosa [6], x-linked retinoschisis [8] and enhanced s-cone syndrome [9] with some success. |
Page: 1